The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684
O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409
Miller, C. R., Buchsbaum, D. J., Reynolds, P. N., Douglas, J. T., Gillespie, G. Y., Mayo, M. S., Raben, D., & Curiel, D. T. (1998) · PubMed · Cited by 346
The role of the nuclear pore complex in adenovirus DNA entry
Greber, U. F., Suomalainen, M., Stidwill, R. P., Boucke, K., Ebersold, M. W., & Helenius, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5998 · Cited by 299
Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., & Kovesdi, I. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6831-6838.1996 · Cited by 288
Henry, L. J., Xia, D., Wilke, M. E., Deisenhofer, J., & Gerard, R. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5239-5246.1994 · Cited by 249
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin
Rihova, B., Bilej, M., Vetvicka, V., Ulbrich, K., Strohalm, J., Kopecek, J., & Duncan, R. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90075-6 · Cited by 192
Self-citationReynolds, P. N., Dmitriev, I. P., & Curiel, D. T. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300941 · Cited by 170
Dash, P. R., Read, M. L., Fisher, K. D., Howard, K. A., Wolfert, M., Oupicky, D., Subr, V., Strohalm, J., Ulbrich, K., & Seymour, L. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3793 · Cited by 161
Self-citationChillón, M., Lee, J. H., Fasbender, A., & Welsh, M. J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300665 · Cited by 135
Romanczuk, H., Galer, C. E., Zabner, J., Barsomian, G., Wadsworth, S. C., & O’Riordan, C. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950016654 · Cited by 134
Croyle, M. A., Yu, Q., & Wilson, J. M. (2000) · Human Gene Therapy · doi:10.1089/10430340050111368 · Cited by 131
Stocks, S. J., Jones, A., Ramey, C. W., & Brooks, D. E. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90520-8 · Cited by 127
Bikfalvi, A., Sauzeau, C., Moukadiri, H., Maclouf, J., Busso, N., Bryckaert, M., Plouët, J., & Tobelem, G. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490108 · Cited by 123
Fisher, K. D., Ulbrich, K., Šubr, V., Ward, C. M., Mautner, V., Blakey, D. C., & Seymour, L. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301230 · Cited by 112
Self-citationThe Adenovirus Protease Is Required for Virus Entry into Host Cells
Cotten, M. L., & WEBER, J. M. (1995) · Virology · doi:10.1006/viro.1995.0022 · Cited by 110
Gu, D., Gonzalez, A. M., Printz, M. A., Doukas, J., Ying, W., D'Andrea, M., Hoganson, D. K., Curiel, D. T., Douglas, J. T., Sosnowski, B. A., et al. (1999) · PubMed · Cited by 102
Receptor-mediated targeted drug or toxin delivery.
Říhová, B. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00084-7 · Cited by 96
Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro
Fredman, J. N., & Engler, J. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3384-3395.1993 · Cited by 80
Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
Stallwood, Y., Fisher, K. D., Gallimore, P. H., & Mautner, V. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301152 · Cited by 63
Self-citationDoukas, J., Hoganson, D. K., Ong, M., Ying, W., Lacey, D. L., Baird, A., Pierce, G. F., & Sosnowski, B. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1459 · Cited by 39
Cited by
Polymers for gene delivery across length scales
Putnam, D. (2006) · Nature Materials · doi:10.1038/nmat1645 · Cited by 572
Modern trends in polymer bioconjugates design
Lutz, J.-F., & Börner, H. G. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.07.005 · Cited by 545
Recent progress in the battle between oncolytic viruses and tumours
Parato, K. A., Senger, D., Forsyth, P. A. J., & Bell, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1750 · Cited by 536
Classification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J.-M. B.-S., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 468
Design of virus-based nanomaterials for medicine, biotechnology, and energy
Wen, A. M., & Steinmetz, N. F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00287g · Cited by 379
Metadata
- Authors
- Fisher, K., Stallwood, Y., Green, N., Ulbrich, K., Mautner, V, & Seymour, L.
- Venue
- Gene Therapy
- Published
- 2001-03-01
- Volume
- 8
- Issue
- 5
- Pages
- 341-348
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2316811173
- Cited by
- 316
- References
- 26
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.